Beijing Yu Sheng Tang Pharmaceutical Group Limited is principally engaged in investment holdings and securities investment. The Company, along with its subsidiaries, is principally engaged in the businesses of supply and procurement of metal minerals, pharmaceutical products, provision of finance and securities investment. The Company has four segments. The supply and procurement segment represents supply and procurement activities in metal minerals and recyclable metal materials. The pharmaceutical segment represents production and sale of Chinese medicine. The provision of finance segment represents provision of short-term loan financing activities. The securities investment segment represents investment activities in equity securities and equity-linked notes. On October 12, 2010, its subsidiary, Weikang Yigan (Beijing) Technology Development Company Limited, acquired remaining 5% interest in Ju Xie Chang (Beijing) Pharmaceutical Company Limited.

Beijing Yu Sheng Tang Pharmaceutical Group Limited ("Yu Sheng Tang") is a company listed on the Main Board of the Hong Kong Stock Exchange (stock code:1141). Yu Sheng Tang and its subsidiaries are principally engaged in pharmaceutical business in the PRC as well as in the supply and procurement business of fuel, metal minerals and recycled metal materials in Asia. We also engaged in financing and securities investment business in Hong Kong